Novo Nordisk
NVO
#14
Rank
C$822.73 B
Marketcap
$185.72
Share price
-0.06%
Change (1 day)
44.10%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of June 2024 : C$12.23 B

According to Novo Nordisk's latest financial reports the company has C$12.23 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$5.93 B28.91%
2022-12-31C$4.60 B36.73%
2021-12-31C$3.36 B25.29%
2020-12-31C$2.68 B-10.6%
2019-12-31C$3.00 B-7.97%
2018-12-31C$3.26 B-14.46%
2017-12-31C$3.82 B-2.98%
2016-12-31C$3.93 B-5.43%
2015-12-31C$4.16 B38.23%
2014-12-31C$3.01 B5.72%
2013-12-31C$2.84 B0.13%
2012-12-31C$2.84 B-8.23%
2011-12-31C$3.10 B8.16%
2010-12-31C$2.86 B10.16%
2009-12-31C$2.60 B11.38%
2008-12-31C$2.33 B64.93%
2007-12-31C$1.41 B34.51%
2006-12-31C$1.05 B13.88%
2005-12-31C$0.92 B16.72%
2004-12-31C$0.79 B15.37%
2003-12-31C$0.68 B68.21%
2002-12-31C$0.40 B-43.39%
2001-12-31C$0.72 B154.22%
2000-12-31C$0.28 B4.18%
1999-12-31C$0.27 B49.83%
1998-12-31C$0.18 B-23.71%
1997-12-31C$0.23 B28.19%
1996-12-31C$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$9.63 B-21.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.56 B-62.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.02 B-26.23%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.88 B-19.24%๐Ÿ‡ซ๐Ÿ‡ท France